Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)
- Conditions
- MicroplasticsChronic Kidney DiseasesNanoplasticsGenotoxic Damage
- Interventions
- Other: Biomonitoring study to detect MNPLs in biological samples and study of their health effects
- Registration Number
- NCT05155267
- Lead Sponsor
- Ricard Marcos
- Brief Summary
Micro and nanoplastics (MNPLs) effects on human heath is still preliminary. Chronic kidney disease (CKD) participants, specially does patients submitted to hemodialysis, are a population high exposed to plastics. The objective of our research is to be able to detect MNPLs on biological fluids of hemodialysis patients as well as their potential genotoxic and immunological damage.
- Detailed Description
The exponential increase in the production/use of plastic translates into a parallel increase of environmental plastic-waste that is continuously degraded into micro and nanoplastics (MNPLs). Information on the MNPLs' effects on human health is still preliminary and, furthermore, the limitations in current methodologies prevent accurate human exposure/risk assessment.
The study aims to analyse specific biomarkers of exposure to MNPLs in humans, as well as biomarkers of genetic damage, which will allow an association between exposure to these plastic materials and the optimisation of different techniques for the detection and characterisation of MNPLs.
The study will evaluate the effect of exposure to MNPLs, analysing the genotoxic damage, different biomarkers of exposure and the effects on microbiota, in different body samples (urine, blood and feces).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Chronic Kidney disease participants (CKD)_HD Biomonitoring study to detect MNPLs in biological samples and study of their health effects CKD submitted to hemodialysis (HD) Chronic Kidney disease participants (CKD)_PD Biomonitoring study to detect MNPLs in biological samples and study of their health effects CKD non-submitted to hemodialysis (pre-dialysis:PD) Controls Biomonitoring study to detect MNPLs in biological samples and study of their health effects Healthy participants
- Primary Outcome Measures
Name Time Method Biomonitoring study to detect the presence of MNPLs in biological fluids Up to 1 year Micro and nanoplastic and/or derivatives, would be evaluated. Characterization of possible biomarkers of early biological effects on human health
Study of the effects of MNPLs on immune system Up to 1 year Impact evaluation of MNPLs on transcriptome, secretome and inflammatory signalling and inflammasome activation. Investigating the effect of MNPLs on the function of the immune system in vivo and in high-risk individuals
Genotoxicity effects of exposure to MNPLs Up to 1 year Genotoxic, chromosome damage evaluation and oxidative DNA damage will be analysed by the Comet assay and the micronucleus assay
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Servicio Murciano de Salud
🇪🇸Murcia, Spain